Therefore, this study aimed to investigate whether WT1-specific CTLs are clonally expanded in the PB outside the tumor site of patients to comprehensively understand the nature of the anti-cancer immune response in patients with solid cancer. The gene discussed is WT1; the disease is neoplasm.